Synthesis of substituted salicylaldehyde derivatives

US9371334B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9371334-B2
Application numberUS-201414496514-A
CountryUS
Kind codeB2
Filing dateSep 25, 2014
Priority dateSep 22, 2010
Publication dateJun 21, 2016
Grant dateJun 21, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Among other things, the present invention encompasses methods of synthesizing salicylaldehyde derivatives comprising the steps of: a) providing salicylaldehyde or a derivative thereof, b) forming an anhydro dimer of the provided salicylaldehyde compound, c) performing one or more chemical transformations on the anhydro dimer and d) hydrolyzing the anhydro dimer to provide a salicylaldehyde derivative different from that provided in step (a).

First claim

Opening claim text (preview).

What is claimed is: 1. A compound of any one of formulae D14 to D18: wherein, R 26 is selected from the group consisting of: hydrogen, halogen, optionally substituted C 1-20 aliphatic, and optionally substituted aryl; R a and R b are, independently at each occurrence, selected from the group consisting of hydrogen, halogen, and optionally substituted C 1-4 aliphatic; Q′ is selected from the group consisting of: halogen, hydroxyl, sulfonate ester, a neutral or cationic nitrogen-containing functional group, and a neutral or cationic phosphorous-containing functional group; and m is from 1 to 10. 2. The compound of claim 1 , wherein Q′ is selected from the group consisting of: bromine, chlorine, iodine, —OH, —OSO 2 R, —N(R) 2 , —N(R) 3 + , —P(R) 3 + , substituted guanidine, guanidinium, and amidine; wherein R is hydrogen; C 1 -C 20 alkyl; C 1 -C 20 alkyl having one or more functional moieties selected from the group consisting of halogen, nitrogen, oxygen, silicon, sulfur, and phosphorus; C 2 -C 20 alkenyl; C 2 -C 20 alkenyl having one or more functional moieties selected from the group consisting of halogen, nitrogen, oxygen, silicon, sulfur, and phosphorus; C 7 -C 20 alkylaryl; C 7 -C 20 alkylaryl having one or more functional moieties selected from the group consisting of halogen, nitrogen, oxygen, silicon, sulfur, and phosphorus; C 7 -C 20 arylalkyl; and C 7 -C 20 arylalkyl having one or more functional moieties selected from the group consisting of halogen, nitrogen, oxygen, silicon, sulfur, and phosphorus. 3. The compound of claim 2 , wherein Q′ is —OH. 4. The compound of claim 2 , wherein Q′ is bromine. 5. The compound of claim 1 , wherein Q′ is a guanidine. 6. The compound of claim 5 , wherein Q′ is 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD). 7. The compound of claim 2 , wherein Q′ is 7-methyl-1,5,7-triazabicyclo[4.4.0]dec-5-ene ([N-methyl TBD] + ). 8. The compound of claim 2 , wherein Q′ is trialkylammonium. 9. The compound of claim 1 , wherein R 26 is selected from the group consisting of: —H, halogen, methyl, ethyl, n-propyl, i-propyl, n-butyl, sec-butyl, and t-butyl. 10. The compound of claim 9 , wherein R 26 is t-butyl. 11. The compound of claim 1 , wherein m is an integer between 1 and 6. 12. The compound of claim 9 , wherein Q′ is TBD. 13. The compound of claim 9 , wherein Q′ is [N-methyl TBD] + .

Assignees

Inventors

Classifications

  • Ortho-condensed systems · CPC title

  • Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00 · CPC title

  • C07D493/08Primary

    Bridged systems · CPC title

  • Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 · CPC title

  • Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9371334B2 cover?
Among other things, the present invention encompasses methods of synthesizing salicylaldehyde derivatives comprising the steps of: a) providing salicylaldehyde or a derivative thereof, b) forming an anhydro dimer of the provided salicylaldehyde compound, c) performing one or more chemical transformations on the anhydro dimer and d) hydrolyzing the anhydro dimer to provide a salicylaldehyde deri…
Who is the assignee on this patent?
Novomer Inc
What technology area does this patent fall under?
Primary CPC classification C07D493/08. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).